A conserved signaling axis linking Drosophila adipose tissue to nephrocyte function reveals how obesity can drive kidney dysfunction and points to new opportunities for therapeutic intervention.

The 36-month PFS rate for patients with del (17p) and/or TP53 mutation was 87% and for patients without del (17p) and TP53 mutation was 89%. The safety profile of BRUKINSA plus venetoclax was ...

Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...

Researchers reveal structure of ancient viral protein appearing in breast cancer, lupus, and ALS, opening new paths for ...

Scientists discovered two brain receptors that act like “switches” to help clear Alzheimer’s plaques, here’s what that means.

Al-Gahtani, S. (2026) Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with ...

Artificial intelligence (AI) is revolutionising the field of drug discovery and disease modelling, with a significant impact ...

VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.

Abstract: Alzheimer’s Disease is a progressive neuro-degenerative disorder and a leading cause of dementia, marked by cognitive decline, memory loss, and behavioral changes. Despite advancements in ...

Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

Based Detection, Linguistic Biomarkers, Machine Learning, Explainable AI, Cognitive Decline Monitoring Share and Cite: de Filippis, R. and Al Foysal, A. (2025) Early Alzheimer’s Disease Detection from ...

Significant treatment options are changing the management of CLL, according to research presented at the ASH Annual Meeting 2025.